Related Experiment Videos

High dose chemo-radiotherapy for sensitive tumors: is sequential better than concurrent drug delivery?

A M Gianni¹, G Bonadonna

¹Cristina Gandini Bone Marrow Transplantation Unit, Division of Medical Oncology, Istituto Nazionale Tumori, Milano, Italy.

European Journal of Cancer & Clinical Oncology

|July 1, 1989

Summary

No abstract available in PubMed .

Related Concept Videos

Articles linked to this work by shared authors, journal, and citation graph.

Dissection of DLBCL microenvironment provides a gene expression-based predictor of survival applicable to formalin-fixed paraffin-embedded tissue.

Annals of oncology : official journal of the European Society for Medical Oncology·2018

Early reduction of serum TARC levels may predict for success of ABVD as frontline treatment in patients with Hodgkin Lymphoma.

Leukemia research·2017

High-dose sequential chemotherapy (HDS) versus PEB chemotherapy as first-line treatment of patients with poor prognosis germ-cell tumors: mature results of an Italian randomized phase II study.

Annals of oncology : official journal of the European Society for Medical Oncology·2014

Synergistic anti-tumor activity and inhibition of angiogenesis by cotargeting of oncogenic and death receptor pathways in human melanoma.

Cell death & disease·2014

Radiotherapy or chemotherapy for clinical stage IIA and IIB seminoma: a systematic review and meta-analysis of patient outcomes.

Annals of oncology : official journal of the European Society for Medical Oncology·2014

PF-03446962, a fully-human monoclonal antibody against transforming growth-factor β (TGFβ) receptor ALK1, in pre-treated patients with urothelial cancer: an open label, single-group, phase 2 trial.

Investigational new drugs·2014

See all related articles